key: cord-0818413-aimm65cr
authors: Lai, Chih-Cheng; Wang, Cheng-Yi; Wang, Ya-Hui; Hsueh, Po-Ren
title: Global coronavirus disease 2019: what has daily cumulative index taught us?
date: 2020-04-29
journal: Int J Antimicrob Agents
DOI: 10.1016/j.ijantimicag.2020.106001
sha: e2784abde3aac2d273a49cbf6248169ccd229543
doc_id: 818413
cord_uid: aimm65cr

ABSTRACT In addition to the absolute case number, a rapid increase in the number of COVID-19 cases within a short time was supposed to result in insufficiency of the healthcare system and further negatively affect patients’ outcomes. This study was conducted to investigate the association between the outcomes of COVID-19 patients and daily cumulative index (DCI), which was defined as the average daily number of new cases of COVID-19 and calculated by cumulative cases/number of days between the first reported case and March 6, 2020 by country. Spearman's rank correlation analyses were conducted to evaluate the relationship between mortality, incidence, and DCI. In this study, we found that DCI was positively correlated with incidence (adjusted risk ratio [aRR] = 1.01, 95% [confidence interval, CI] = 1.00-1.02, p < 0.01). Higher correlation between mortality and DCI (mortality rate: r = 0.397, p = 0.018; mortality per 1,000,000 people: r = 0.0.428, p = 0.004) was observed than disease incidence. DCI remained statistically associated with mortality per 1,000,000 people after adjustment of Health Care Index (aRR = 1.02, 95% CI = 1.01-1.03, p < 0.001) or Healthcare Access and Quality Index (aRR = 1.02, 95% CI = 1.01-1.04, p < 0.01. Reducing DCI through strict infection control measures can help slow the increasing number of COVID-19 cases and further improve outcome in COVID-19 patients.

From the first case of coronavirus disease 2019 (COVID-19) caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously known as 2019-nCoV) emerging in Wuhan, China at the end of 2019, the number of COVID-19 cases has exponentially increased across the whole China and has become a global pandemic [1] [2] [3] [4] [5] [6] . Up to March 6, 2020, there was a total of 98,129 cases in the world, and 3380 deaths were reported [7] . Although most of the cases and deaths occurred in China, the increasing trend of incidence and mortality in China seems to have stabilized. In contrast, a dramatic increase in the number of COVID-19 cases has been reported in Europe, the United States, the Republic of Korea, and Iran since the end of February. Based on the earlier experience in Hubei, China [8] , the rapid escalation in the number of COVID-19 cases may lead to an insufficiency of healthcare resources and further result in poor outcome in patients. Therefore, we postulate that a similar association can be observed worldwide, and thus we conducted an analysis to find a possible association between the outcome of mortality and the case number of COVID-19.

To prevent the spread of COVID-19 and its associated morbidity and mortality, early detection and appropriate management of patients with COVID-19 are necessary.

All these works are both time-and resource-consuming for the healthcare system and staff. For example, to collect specimens for SARS-CoV-2 detection from a COVID-19 case suspect, a healthcare worker needs to wear personal protective equipment (PPE) in an isolation room. To treat a patient with COVID-19, a hospital needs to provide adequate manpower and equipment. Thus, it can be expected that a large increase in the number of COVID-19 cases can cause a huge burden on healthcare resources and possible burn-out of healthcare staff. In addition to the absolute case number, our hypothesis is that a rapid increase in the number of COVID-19 cases within a short time can result in insufficiency of the healthcare system and further negatively affect patient outcome.

Daily cumulative index (DCI) was defined as the average daily number of new cases and calculated by cumulative cases/number of days between the first reported case and March 6, 2020. As the quality and availability of the healthcare system varies in each country, which may also affect patient outcome, we used two more indexes, namely the Health Care Index (HCI) (https://www.numbeo.com/health-care/rankings_by_country.jsp. Access on March 6, 2020) and Healthcare Access and Quality Index (HAQI) [9, 10] , to represent the performance of the healthcare system in each country in this analysis. The HCI is based on surveys from visitors of one open website and questions for these surveys.

The indices are updated continuously and we used the version -Health Care Index 2020 in this study [10] . The HAQI uses 32 scaled cause values, which comprised vaccine-preventable diseases; infectious diseases and maternal and child health;

non-communicable diseases, including cancers, cardiovascular diseases, and other non-communicable diseases such as diabetes; and gastrointestinal conditions, and providing an overall score of 0-100 of personal healthcare access and quality by location over time [9] . Its most recent version was using the data of 2016, which was used in this study. Spearman's rank correlation analyses were conducted to evaluate the relationship between mortality, incidence, and DCI. A negative binomial regression model was used to estimate the risk ratios and 95 % confidence interval (CI) between DCI and incidence. Statistical analyses were performed using the SAS software version 9.4 (SAS Institute Inc., Cary, NC). A p value of <0.05 indicated statistical significance in all analyses.

To date, China had the highest number of COVID-19 cases (n = 80552), followed by the Republic of Korea (n = 6284), Italy (n = 3858), and Iran (n = 3513)( and that higher DCI was associated with higher disease incidence ( Table 2 ). In addition, both HCI and HAQI were positively correlated with incidence (HCI: aRR = 1.06, 95% CI = 1.02-1.11, p < 0.01; HAQI: aRR = 1.10, 95% CI = 1.07-1.12, p < 0.001). Furthermore, we found that both case fatality rate and mortality per 1,000,000 people were positively correlated with incidence (mortality rate: r = 0.248, p = 0.018; mortality per 1,000,000 people: r = 0.298, p = 0.004) ( Figures 1A and 1B) . Moreover, higher correlation between mortality and DCI (case fatality rate: r = 0.397, p = 0.018; mortality per 1,000,000 people: r = 0.0.428, p = 0.004) was observed than disease incidence ( Figures 1C and 1D) . Finally, DCI remained statistically associated with mortality per 1,000,000 people after adjustment of HCI (aRR = 1.02, 95% CI = 1.01-1.03, p < 0.001) or HAQI (aRR = 1.02, 95% CI = 1.01-1.04, p < 0.01).

This study had several significant findings. Firstly, we found that DCI was positively correlated with disease incidence. It is reasonable that a rapid increase in the number of cases can facilitate the spread of COVID-19 and further result in even more cases. Secondly, higher level of healthcare performance was associated with higher incidence of COVID-19. This may be explained by the fact that countries with higher HCI or HAQI had better ability to detect COVID-19; thus, more cases may be identified. Finally, we found that DCI was positively correlated with mortality and that the significant association between DCI and mortality remained unchanged after adjustment of the level of healthcare performance -HCI or HCAI. Moreover, the four countries with the highest DCI -China, Iran, the Republic of Korea, and Italyhad more death per 1,000,000 people than other countries. In contrast, although we showed similar findings with those of Ji et al. [8] , in which a larger number of infections in the earlier China was associated with higher mortality. Our previous study also demonstrated that the incidence and mortality rates were correlated with DCI, especially in countries with local transmission [10] . However, the correlation and DCI observed in the present study was not as good as that in the earlier China study [8] but DCI was found to be more correlated with mortality than incidence. Our Table 2 Risk ratios (RR) between daily cumulative index (dci) and incidence, as analyzed using negative binominal regression models 

A novel coronavirus emerging in china -key questions for impact assessment

A novel coronavirus from patients with pneumonia in China

Pandemic potential of 2019-nCoV

Clinical characteristics of coronavirus disease 2019 in China

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus

COVID-19): The epidemic and the challenges

Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths

6-sitrep-46-covid-19.pdf?sfvrsn=96b04adf_4. Accessed on

Potential association between COVID-19 mortality and health-care resource availability

Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study

Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status

Ethical Approval: No need